Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Sulindac was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Sulindac include Roussel Delma Pharmaceuticals, Shanghai Trifecta Pharma, Chemcopia, Anant Pharmaceuticals, Aurore Life Sciences, Olon, Repu Pham.& Chem, Amitychem, Dideu, Piramal Pharma Solutions, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Sulindac, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sulindac by region & country, by Purity, and by Application.
The Sulindac market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulindac.
Market Segmentation
Report Metric
Details
Report Title
Sulindac- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Market Size Available for Years
2024-2030
Global Sulindac Companies Covered
Roussel Delma Pharmaceuticals
Shanghai Trifecta Pharma
Chemcopia
Anant Pharmaceuticals
Aurore Life Sciences
Olon
Repu Pham.& Chem
Amitychem
Dideu
Piramal Pharma Solutions
Leader Chemical
SST Corporation
Global Sulindac Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sulindac Market, Segment by Type
Below 98%
Above 98%
Global Sulindac Market, Segment by Application
Arthritis
Gout
Musculoskeletal Injuries
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sulindac manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sulindac in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sulindac in country level. It provides sigmate data by Purity, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Sulindac Product Introduction
1.2 Global Sulindac Market Size Forecast
1.2.1 Global Sulindac Sales Value (2019-2030)
1.2.2 Global Sulindac Sales Volume (2019-2030)
1.2.3 Global Sulindac Sales Price (2019-2030)
1.3 Sulindac Market Trends & Drivers
1.3.1 Sulindac Industry Trends
1.3.2 Sulindac Market Drivers & Opportunity
1.3.3 Sulindac Market Challenges
1.3.4 Sulindac Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sulindac Players Revenue Ranking (2023)
2.2 Global Sulindac Revenue by Company (2019-2024)
2.3 Global Sulindac Players Sales Volume Ranking (2023)
2.4 Global Sulindac Sales Volume by Company Players (2019-2024)
2.5 Global Sulindac Average Price by Company (2019-2024)
2.6 Key Manufacturers Sulindac Manufacturing Base and Headquarters
2.7 Key Manufacturers Sulindac Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Sulindac
2.9 Sulindac Market Competitive Analysis
2.9.1 Sulindac Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Sulindac Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulindac as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Purity
3.1 Introduction by Purity
3.1.1 Below 98%
3.1.2 Above 98%
3.2 Global Sulindac Sales Value by Purity
3.2.1 Global Sulindac Sales Value by Purity (2019 VS 2023 VS 2030)
3.2.2 Global Sulindac Sales Value, by Purity (2019-2030)
3.2.3 Global Sulindac Sales Value, by Purity (%) (2019-2030)
3.3 Global Sulindac Sales Volume by Purity
3.3.1 Global Sulindac Sales Volume by Purity (2019 VS 2023 VS 2030)
3.3.2 Global Sulindac Sales Volume, by Purity (2019-2030)
3.3.3 Global Sulindac Sales Volume, by Purity (%) (2019-2030)
3.4 Global Sulindac Average Price by Purity (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Arthritis
4.1.2 Gout
4.1.3 Musculoskeletal Injuries
4.1.4 Others
4.2 Global Sulindac Sales Value by Application
4.2.1 Global Sulindac Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sulindac Sales Value, by Application (2019-2030)
4.2.3 Global Sulindac Sales Value, by Application (%) (2019-2030)
4.3 Global Sulindac Sales Volume by Application
4.3.1 Global Sulindac Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Sulindac Sales Volume, by Application (2019-2030)
4.3.3 Global Sulindac Sales Volume, by Application (%) (2019-2030)
4.4 Global Sulindac Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Sulindac Sales Value by Region
5.1.1 Global Sulindac Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sulindac Sales Value by Region (2019-2024)
5.1.3 Global Sulindac Sales Value by Region (2025-2030)
5.1.4 Global Sulindac Sales Value by Region (%), (2019-2030)
5.2 Global Sulindac Sales Volume by Region
5.2.1 Global Sulindac Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Sulindac Sales Volume by Region (2019-2024)
5.2.3 Global Sulindac Sales Volume by Region (2025-2030)
5.2.4 Global Sulindac Sales Volume by Region (%), (2019-2030)
5.3 Global Sulindac Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Sulindac Sales Value, 2019-2030
5.4.2 North America Sulindac Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Sulindac Sales Value, 2019-2030
5.5.2 Europe Sulindac Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Sulindac Sales Value, 2019-2030
5.6.2 Asia Pacific Sulindac Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Sulindac Sales Value, 2019-2030
5.7.2 South America Sulindac Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Sulindac Sales Value, 2019-2030
5.8.2 Middle East & Africa Sulindac Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sulindac Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sulindac Sales Value
6.2.1 Key Countries/Regions Sulindac Sales Value, 2019-2030
6.2.2 Key Countries/Regions Sulindac Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Sulindac Sales Value, 2019-2030
6.3.2 United States Sulindac Sales Value by Purity (%), 2023 VS 2030
6.3.3 United States Sulindac Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sulindac Sales Value, 2019-2030
6.4.2 Europe Sulindac Sales Value by Purity (%), 2023 VS 2030
6.4.3 Europe Sulindac Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sulindac Sales Value, 2019-2030
6.5.2 China Sulindac Sales Value by Purity (%), 2023 VS 2030
6.5.3 China Sulindac Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sulindac Sales Value, 2019-2030
6.6.2 Japan Sulindac Sales Value by Purity (%), 2023 VS 2030
6.6.3 Japan Sulindac Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sulindac Sales Value, 2019-2030
6.7.2 South Korea Sulindac Sales Value by Purity (%), 2023 VS 2030
6.7.3 South Korea Sulindac Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sulindac Sales Value, 2019-2030
6.8.2 Southeast Asia Sulindac Sales Value by Purity (%), 2023 VS 2030
6.8.3 Southeast Asia Sulindac Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sulindac Sales Value, 2019-2030
6.9.2 India Sulindac Sales Value by Purity (%), 2023 VS 2030
6.9.3 India Sulindac Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roussel Delma Pharmaceuticals
7.1.1 Roussel Delma Pharmaceuticals Company Information
7.1.2 Roussel Delma Pharmaceuticals Introduction and Business Overview
7.1.3 Roussel Delma Pharmaceuticals Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roussel Delma Pharmaceuticals Sulindac Product Offerings
7.1.5 Roussel Delma Pharmaceuticals Recent Development
7.2 Shanghai Trifecta Pharma
7.2.1 Shanghai Trifecta Pharma Company Information
7.2.2 Shanghai Trifecta Pharma Introduction and Business Overview
7.2.3 Shanghai Trifecta Pharma Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Shanghai Trifecta Pharma Sulindac Product Offerings
7.2.5 Shanghai Trifecta Pharma Recent Development
7.3 Chemcopia
7.3.1 Chemcopia Company Information
7.3.2 Chemcopia Introduction and Business Overview
7.3.3 Chemcopia Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Chemcopia Sulindac Product Offerings
7.3.5 Chemcopia Recent Development
7.4 Anant Pharmaceuticals
7.4.1 Anant Pharmaceuticals Company Information
7.4.2 Anant Pharmaceuticals Introduction and Business Overview
7.4.3 Anant Pharmaceuticals Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Anant Pharmaceuticals Sulindac Product Offerings
7.4.5 Anant Pharmaceuticals Recent Development
7.5 Aurore Life Sciences
7.5.1 Aurore Life Sciences Company Information
7.5.2 Aurore Life Sciences Introduction and Business Overview
7.5.3 Aurore Life Sciences Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Aurore Life Sciences Sulindac Product Offerings
7.5.5 Aurore Life Sciences Recent Development
7.6 Olon
7.6.1 Olon Company Information
7.6.2 Olon Introduction and Business Overview
7.6.3 Olon Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Olon Sulindac Product Offerings
7.6.5 Olon Recent Development
7.7 Repu Pham.& Chem
7.7.1 Repu Pham.& Chem Company Information
7.7.2 Repu Pham.& Chem Introduction and Business Overview
7.7.3 Repu Pham.& Chem Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Repu Pham.& Chem Sulindac Product Offerings
7.7.5 Repu Pham.& Chem Recent Development
7.8 Amitychem
7.8.1 Amitychem Company Information
7.8.2 Amitychem Introduction and Business Overview
7.8.3 Amitychem Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Amitychem Sulindac Product Offerings
7.8.5 Amitychem Recent Development
7.9 Dideu
7.9.1 Dideu Company Information
7.9.2 Dideu Introduction and Business Overview
7.9.3 Dideu Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Dideu Sulindac Product Offerings
7.9.5 Dideu Recent Development
7.10 Piramal Pharma Solutions
7.10.1 Piramal Pharma Solutions Company Information
7.10.2 Piramal Pharma Solutions Introduction and Business Overview
7.10.3 Piramal Pharma Solutions Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Piramal Pharma Solutions Sulindac Product Offerings
7.10.5 Piramal Pharma Solutions Recent Development
7.11 Leader Chemical
7.11.1 Leader Chemical Company Information
7.11.2 Leader Chemical Introduction and Business Overview
7.11.3 Leader Chemical Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Leader Chemical Sulindac Product Offerings
7.11.5 Leader Chemical Recent Development
7.12 SST Corporation
7.12.1 SST Corporation Company Information
7.12.2 SST Corporation Introduction and Business Overview
7.12.3 SST Corporation Sulindac Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 SST Corporation Sulindac Product Offerings
7.12.5 SST Corporation Recent Development
8 Industry Chain Analysis
8.1 Sulindac Industrial Chain
8.2 Sulindac Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sulindac Sales Model
8.5.2 Sales Channel
8.5.3 Sulindac Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Sulindac Market Trends
Table 2. Sulindac Market Drivers & Opportunity
Table 3. Sulindac Market Challenges
Table 4. Sulindac Market Restraints
Table 5. Global Sulindac Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Sulindac Revenue Market Share by Company (2019-2024)
Table 7. Global Sulindac Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Sulindac Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Sulindac Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Sulindac Manufacturing Base and Headquarters
Table 11. Key Manufacturers Sulindac Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Sulindac
Table 13. Global Sulindac Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulindac as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Sulindac Sales Value by Purity: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Sulindac Sales Value by Purity (2019-2024) & (US$ Million)
Table 18. Global Sulindac Sales Value by Purity (2025-2030) & (US$ Million)
Table 19. Global Sulindac Sales Market Share in Value by Purity (2019-2024)
Table 20. Global Sulindac Sales Market Share in Value by Purity (2025-2030)
Table 21. Global Sulindac Sales Volume by Purity: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Sulindac Sales Volume by Purity (2019-2024) & (Tons)
Table 23. Global Sulindac Sales Volume by Purity (2025-2030) & (Tons)
Table 24. Global Sulindac Sales Market Share in Volume by Purity (2019-2024)
Table 25. Global Sulindac Sales Market Share in Volume by Purity (2025-2030)
Table 26. Global Sulindac Price by Purity (2019-2024) & (US$/Ton)
Table 27. Global Sulindac Price by Purity (2025-2030) & (US$/Ton)
Table 28. Global Sulindac Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Sulindac Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Sulindac Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Sulindac Sales Market Share in Value by Application (2019-2024)
Table 32. Global Sulindac Sales Market Share in Value by Application (2025-2030)
Table 33. Global Sulindac Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Sulindac Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Sulindac Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Sulindac Sales Market Share in Volume by Application (2019-2024)
Table 37. Global Sulindac Sales Market Share in Volume by Application (2025-2030)
Table 38. Global Sulindac Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Sulindac Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Sulindac Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
Table 41. Global Sulindac Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Sulindac Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Sulindac Sales Value by Region (2019-2024) & (%)
Table 44. Global Sulindac Sales Value by Region (2025-2030) & (%)
Table 45. Global Sulindac Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Sulindac Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Sulindac Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Sulindac Sales Volume by Region (2019-2024) & (%)
Table 49. Global Sulindac Sales Volume by Region (2025-2030) & (%)
Table 50. Global Sulindac Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Sulindac Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Sulindac Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Sulindac Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Sulindac Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Sulindac Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Sulindac Sales Volume, (2025-2030) & (Tons)
Table 57. Roussel Delma Pharmaceuticals Company Information
Table 58. Roussel Delma Pharmaceuticals Introduction and Business Overview
Table 59. Roussel Delma Pharmaceuticals Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. Roussel Delma Pharmaceuticals Sulindac Product Offerings
Table 61. Roussel Delma Pharmaceuticals Recent Development
Table 62. Shanghai Trifecta Pharma Company Information
Table 63. Shanghai Trifecta Pharma Introduction and Business Overview
Table 64. Shanghai Trifecta Pharma Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. Shanghai Trifecta Pharma Sulindac Product Offerings
Table 66. Shanghai Trifecta Pharma Recent Development
Table 67. Chemcopia Company Information
Table 68. Chemcopia Introduction and Business Overview
Table 69. Chemcopia Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. Chemcopia Sulindac Product Offerings
Table 71. Chemcopia Recent Development
Table 72. Anant Pharmaceuticals Company Information
Table 73. Anant Pharmaceuticals Introduction and Business Overview
Table 74. Anant Pharmaceuticals Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. Anant Pharmaceuticals Sulindac Product Offerings
Table 76. Anant Pharmaceuticals Recent Development
Table 77. Aurore Life Sciences Company Information
Table 78. Aurore Life Sciences Introduction and Business Overview
Table 79. Aurore Life Sciences Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. Aurore Life Sciences Sulindac Product Offerings
Table 81. Aurore Life Sciences Recent Development
Table 82. Olon Company Information
Table 83. Olon Introduction and Business Overview
Table 84. Olon Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. Olon Sulindac Product Offerings
Table 86. Olon Recent Development
Table 87. Repu Pham.& Chem Company Information
Table 88. Repu Pham.& Chem Introduction and Business Overview
Table 89. Repu Pham.& Chem Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Repu Pham.& Chem Sulindac Product Offerings
Table 91. Repu Pham.& Chem Recent Development
Table 92. Amitychem Company Information
Table 93. Amitychem Introduction and Business Overview
Table 94. Amitychem Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 95. Amitychem Sulindac Product Offerings
Table 96. Amitychem Recent Development
Table 97. Dideu Company Information
Table 98. Dideu Introduction and Business Overview
Table 99. Dideu Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 100. Dideu Sulindac Product Offerings
Table 101. Dideu Recent Development
Table 102. Piramal Pharma Solutions Company Information
Table 103. Piramal Pharma Solutions Introduction and Business Overview
Table 104. Piramal Pharma Solutions Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 105. Piramal Pharma Solutions Sulindac Product Offerings
Table 106. Piramal Pharma Solutions Recent Development
Table 107. Leader Chemical Company Information
Table 108. Leader Chemical Introduction and Business Overview
Table 109. Leader Chemical Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 110. Leader Chemical Sulindac Product Offerings
Table 111. Leader Chemical Recent Development
Table 112. SST Corporation Company Information
Table 113. SST Corporation Introduction and Business Overview
Table 114. SST Corporation Sulindac Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 115. SST Corporation Sulindac Product Offerings
Table 116. SST Corporation Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Sulindac Downstream Customers
Table 120. Sulindac Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Sulindac Product Picture
Figure 2. Global Sulindac Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Sulindac Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Sulindac Sales Volume (2019-2030) & (Tons)
Figure 5. Global Sulindac Sales Price (2019-2030) & (US$/Ton)
Figure 6. Sulindac Report Years Considered
Figure 7. Global Sulindac Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Sulindac Players Sales Volume Ranking (2023) & (US$ Million)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Sulindac Revenue in 2023
Figure 10. Sulindac Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Below 98% Picture
Figure 12. Above 98% Picture
Figure 13. Global Sulindac Sales Value by Purity (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Sulindac Sales Value Market Share by Purity, 2023 & 2030
Figure 15. Global Sulindac Sales Volume by Purity (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Sulindac Sales Volume Market Share by Purity, 2023 & 2030
Figure 17. Global Sulindac Price by Purity (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Arthritis
Figure 19. Product Picture of Gout
Figure 20. Product Picture of Musculoskeletal Injuries
Figure 21. Product Picture of Others
Figure 22. Global Sulindac Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Sulindac Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Sulindac Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 25. Global Sulindac Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Sulindac Price by Application (2019-2030) & (US$/Ton)
Figure 27. North America Sulindac Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Sulindac Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 30. Europe Sulindac Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Sulindac Sales Value by Region (%), 2023 VS 2030
Figure 33. South America Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 34. South America Sulindac Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Sulindac Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Sulindac Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Sulindac Sales Volume (%), (2019-2030)
Figure 39. United States Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 41. United States Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 44. Europe Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 45. China Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 47. China Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 50. Japan Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 53. South Korea Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 56. Southeast Asia Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 57. India Sulindac Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Sulindac Sales Value by Purity (%), 2023 VS 2030
Figure 59. India Sulindac Sales Value by Application (%), 2023 VS 2030
Figure 60. Sulindac Industrial Chain
Figure 61. Sulindac Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Sulindac was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
North American market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Sulindac was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Sulindac include Roussel Delma Pharmaceuticals, Shanghai Trifecta Pharma, Chemcopia, Anant Pharmaceuticals, Aurore Life Sciences, Olon, Repu Pham.& Chem, Amitychem, Dideu, Piramal Pharma Solutions, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Sulindac, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Sulindac by region & country, by Purity, and by Application.
The Sulindac market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sulindac.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sulindac manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Sulindac in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Sulindac in country level. It provides sigmate data by Purity, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
The global Sulindac revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-07
Pages: 121
USD 4350.00
(Single User License)
The global Sulindac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-07
Pages: 103
USD 2900.00
(Single User License)
The global market for Sulindac was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
The global market for Sulindac was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 101
USD 2900.00
(Single User License)
The global Sulindac market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 93
USD 4250.00
(Single User License)
The global Sulindac market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 154
USD 4900.00
(Single User License)
The global Sulindac market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 142
USD 2900.00
(Single User License)
The global market for Sulindac was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 113
USD 3950.00
(Single User License)
The global Sulindac market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
The global Sulindac market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 160
USD 4900.00
(Single User License)
The global Sulindac revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-06-07
Pages: 121
The global Sulindac market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-06-07
Pages: 103
The global market for Sulindac was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
The global market for Sulindac was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 101
The global Sulindac market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 93
The global Sulindac market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 154
The global Sulindac market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 142
The global market for Sulindac was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 113
The global Sulindac market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
The global Sulindac market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 160
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database